Table 1.
Table of Demographics for patients in this analysis
| Variable | ZIKV Patients (n=32) | DENV Patients (n=59) | Household Patients (n=81) | Undefined fever events (n=259) |
|---|---|---|---|---|
| Median age (IQR) | 33.5 (12.2) | 26 (22) | 42 (27) | 31 (22.5) |
| Gender female, n (%) | 19 (59%) | 34 (58%) | 45 (56%) | 165 (64%) |
| Days after symptoms onset at enrolment | ||||
| 0 day | 1 (3%) | 0 (0%) | N/A | 2 (1%) |
| 1 days | 2 (6%) | 2 (3%) | N/A | 30 (12%) |
| 2 days | 10 (31%) | 5 (8%) | N/A | 47 (18%) |
| 3 days | 8 (25%) | 8 (14%) | N/A | 46 (18%) |
| 4 days | 5 (16%) | 10 (17%) | N/A | 48 (19%) |
| 5 days | 4 (13%) | 12 (20%) | N/A | 41 (16%) |
| 6 days | 2 (6%) | 12 (20%) | N/A | 37 (14%) |
| 7 days | 0 (0%) | 10 (17%) | N/A | 8 (3%) |
| Clinical symptoms, n (%) | ||||
| Fever | 22 (69%) | 57 (97%) | 0 (0%) | 228 (88%) |
| Non-purulent conjunctivitis or conjunctival hyperemia | 26 (81%) | 29 (49%) | 0 (0%) | 149 (58%) |
| Rash | 24 (75%) | 51 (86%) | 8 (10%) | 127 (49%) |
| Pruritus | 25 (78%) | 50 (85%) | 19 (24%) | 150 (58%) |
| Arthralgia | 26 (81%) | 54 (92%) | 21 (26%) | 243 (94%) |
| Myalgia | 32 (100%) | 56 (94%) | 35 (43%) | 248 (96%) |
| Headache | 28 (88%) | 59 (100%) | 49 (61%) | 250 (97%) |
| Diarrhea | 12 (38%) | 36 (61%) | 16 (20%) | 127 (49%) |
| Malaise | 31 (97%) | 59 (100%) | 81 (100%) | 258 (99%) |
| Eye pain | 25 (78%) | 45 (76%) | 0 (0%) | 205 (79%) |
| Median number of symptoms (IQR) | 8 (2) | 9 (1) | 2 (2) | 8 (2) |